Performance

MLTX +18.72%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
MLTX	+9.45%	-4.25%	+18.72%	—	-56.90%	0.53	0.00%

Summary

MLTX at a glance

MLTX returned +18.72% over the past year. Its worst drop in that year was -56.90%, smaller than 15% of stocks on Redstone, and its Sharpe ratio of 0.53 beats 52% of stocks on Redstone. It pays no dividends.

Ranking

How MLTX ranks

Current Drawdown

-43.05%

Rolling Volatility

85.57%

Actions

Metrics

Risk Indicators

Alpha24.98%

Beta1.49x

Sharpe0.53

Sortino0.96

Omega1.11

Calmar0.33

Martin1.70

Profile

About MLTX

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.1B
Listed: Apr 2022
Employees: 130
Headquarters: Zug, V8
Website: moonlaketx.com

Comparisons

MLTX: MoonLake Immunotherapeutics

MLTX at a glance

How MLTX ranks

Current Drawdown

Rolling Volatility

About MLTX

Related comparisons